References
Ehrlich, P., Über den jetzigen Stand der Chemotherapie, Chem. Ber., 42 (1909) 17.
Marshall, G.R. and Naylor, C.B., Use of molecular graphics for structural analysis of small molecules, In Hansch, C., Sammes, P.G., Taylor, J.B. and Ramsden, C.A. (Eds.) Comprehensive medicinal chemistry: Vol. 4, Pergamon Press, Oxford, 1990, pp. 431–458.
Marshall, G.R., Barry, C.D., Bosshard, H.E., Dammkoehler, R.A. and Dunn, D.A., The conformational parameter in drug design, Computer Assisted Drug Design, ACS Symp. Ser. 112, 1979, pp. 205–226.
Gund, P., Pharmacophoric pattern searching and receptor mapping, Ann. Rep. Med. Chem., 14 (1979) 299–308.
Ghose, A.K., Logan, M.E., Treasurywala, A.M., Wang, H., Wahl, R.C., Tomczuk, B.E., Gowravaram, M.R., Jaeger, E.P. and Wendoloski, J.J., Determination of pharmacophoric geometry for collagenase inhibitors using a novel computational method and its verification using molecular dynamics, NMR and X-ray crystallography, J. Am. Chem. Soc., 17 (1995) 4671–82.
Humblet, C. and Marshall, G.R. Pharmacophore identification and receptor mapping, Ann. Rep. Med. Chem., 15 (1980) 267–276.
Kelebe, G., Structural alignment of molecules, In Kubinyi, H. (Ed.) 3D QSAR in drug design: theory, methods and applications, ESCOM, Leiden, 1993, pp. 173–199.
Clark, D.E., Willet, P. and Kenny, P.W., Pharmacophoric pattern matching in files of three-dimensional chemical structures: Use of smoothed bounded distances for incompletely specified query patterns, J. Mol. Graph., 9 (1991) 157–160.
Johnson, W.H., Roberts, N.A. and Borkakoti, N., Collagenase inhibitors: Their design and potential therapeutic use, J. Enzyme Inhib., 2 (1987) 1–22.
Schwartz, M.A. and Van Wart, H.E., Synthetic inhibitors of bacterial and mammalian interstitial collagenase, Prog. Med. Chem, 29 (1992) 271–334.
Matthews, B.W., Structural basis of the action of thermolysin and related Zn peptidases, Acc. Chem. Res., 21(1988) 333–340.
Crippen, G.M., Quantitative structure-activity relationships by distance geometry: systematic analysis of dihydrofolate reducatase inhibitors, J. Med. Chem. 23 (1980) 599–606.
Ghose, A.K., Crippen, G.M., Revankar, G.R., McKernan, P.A., Smee, D.F. and Robins, R.K., Analysis of the in vitro antiviral activity of certain ribonucleosides against parainfluenza virus using a novel computer aided receptor modeling procedure, J. Med. Chem., 32 (1989) 746–756.
Viswanadhan, V.N., Ghose, A.K., Revankar, G.R. and Robins, R.K., Atomic physicochemical parameters of three-dimensional structure directed quantitative structure-activity relationships: 4. Additional parameters for hydrophobic and dispersive interactions and their application for an automated superposition of certain naturally occurring nucleoside antibiotics, J. Chem. Inf. Comput. Sci., 29 (1989) 163–172.
Martin, Y.C., Bures, M.G., Danaher, E.A., DeLazzer, J., Lico, I. and Pavlik, P.A. A fast new approach to pharmacophore mapping and its application to dopaminergic and benzodiazepine agonists, J. Comput.-Aided Mol. Design, 7 (1993) 83–102.
Jones, G., Willet, P. and Glen, R.C., A genetic algorithm for flexible molecular overlay and pharma-cophore elucidation, J. Comput.-Aided Mol. Design, 9 (1995) 532–549.
Crippen, G.M. and Havel, T.F., Stable calculation of coordinates from distance information, Acta Crystalloger., Sect. A, 34 (1978) 282.
Sheridan, R.P., Nilakantan, R., Dixon, J.S. and Venkataraghavan, R. The ensemble distance geometry: Application to the nicotinic pharmacophore, J. Med. Chem., 29 (1986) 899–906.
Crippen, G.M., Distance geometry approach to rationalizing binding data, J. Med. Chem., 22 (1979) 988–997.
Ghose, A.K. and Crippen, G.M., Distance geometry approach to modeling receptor sites, In Hansch, C., Sammes, P.G., Taylor, J.B. and Ramsden, C.A. (Eds) Comprehensive medicinal chemistry, Vol. 4, Pergamon Press, 1990, pp. 715–734.
Ghose, A.K. and Crippen, G.M., Geometrically feasible binding models of the flexible ligand molecule at the receptor site, J. Comp. Chem., 6 (1985) 350–359.
Motoc, I., Dammkoehler, R.A. and Marshall, G.R. Three-dimensional structure-activity relationships and biological receptor mapping, In Trinajstic, N. (Ed.) Mathematical and computational concepts in chemistry, Ellis Horwood Ltd., Chichester, 1986, pp. 222–251.
Kuhl, F.S., Crippen, G.M. and Friesen, D.K., A combinatorial algorithm for calculating ligand binding, J. Comput. Chem., 5 (1984) 24–34.
Tripos Associates, Inc., 1699 S. Hanley Road, St. Louis, MO 63144, U.S.A.
Payne, A.W. and Glen, R.C., Molecular recognition using a binary genetic search algorithm, J. Mol. Graph., 11 (1993) 74–91.
Bohacek, R., Delombaert, S., McMartin, C., Priestle, J., and Grutter, M., 3-Dimensional models of ACE and NEP inhibitors and their use in the design of potent dual ACE/NEP inhibitors, J. Am. Chem. Soc., 118 (1996) 8231–8249.
Dalpaiz, A., Bertolasi, V., Borea, P.A., Nacci, V., Fiorini, I., Campiani, G., Mennini, T., Manzoni, C., Novellino, E. and Greco, G., A concerted study using binding measurements, X-ray structural data and molecular modeling on the stereochemical features responsible for the affinity of 6-arylpyrrolo [2,1-D][1,5]benzothiazepines toward mitochondrial benzodiazepine receptors, J. Med. Chem., 38 (1995) 4730–4738.
Froimowitz, M., Patrick, K.S. and Cody, V., Conformational analysis of methylphenidate and its structural relationship to other dopamine reuptake blockers such as CFT, Pharmaceutic. res., 12 (1995) 1430–1434.
Bandoli, G., Dolmella, A., Gatto, S. and Nicolini, M., X-ray studies, empirical, semiempirical and statistical calculations on a series of thyrotropin-releasing-hormone derivatives, J. Mol. Struct., 345 (1995) 213–225.
Morita, H., Yun, Y.S., Takeya, K., Itokawa, H. and Shiro, M., Conformational analysis of a cyclic hexa-peptide, segetalin-A from Vaccariasegetalis, Tetrahedron, 51 (1995) 5987–6002.
Brandt, W., Drosihin, S., Haurand, M., Holzgrabe, U. and Nachtsheim, C., Search for the phar-macophore in k-agonistic diazabicyclo[3.3.1]nonan-9-one-1,5-diesters and arylacetamides, Arch. der Pharmazie, 329 (1996) 311–323.
Hennig, P., Raimbaud, E., Thurieau, C., Volland, J.P., Michel, A. and Fauchere, J.L., Solution conformation by NMR and molecular modeling of 3 sulfide-free somatostatin octapeptide analogs compared to angiopeptin, J. Comput.-Aided Mol. Design, 10 (1996) 83–86.
Boger, D.L. and Zhou, J.C., N-Desmethyl derivatives of Deoxybouvardin and RA-VII: synthesis and evaluation, J. Am. Chem. Soc., 117 (1995) 7364–7378.
Morita, H., Yun, Y.s., Takeya, K., Itokawa, H. and Shiro, M., Conformational analysis of a cyclic hexapeptide, segetalin-A from Vaccariasegetalis, Tetrahedron, 51 (1995) 5987–6002.
Sefler, A.M., He, J.X., Sawyer, T.K., Holub, K.E., Omecinsky, D.O., Reily, M.D., Thanball, V., Akunne, H.C. and Cody, W.L., Design and structure-activity relationships of C-terminal cyclic neu-rotensin fragment analogs, J. Med. Chem., 38 (1995) 249–257.
Nicklaus, M.C., Wang, S., Driscoll, J.S. and Milne, G.W., Conformational changes of small molecules binding to proteins, Bioorg. Med. Chem., 3 (1995) 411–428.
MDL Information Systems Inc., 14600 Cataline Street, San Leandro, CA 94577, U.S.A.
AM Technologies Inc., 14785 Omicron Dr., Texas Research Park, San Antonio, TX 78245, U.S.A.
Ghose, A.K. and Crippen, G.M., A general distance geometry three-dimensional receptor model for dihydrofolate reductase inhibitors, J. Med. Chem., 27 (1984) 901–914.
Ghose, A.K. and Crippen, G.M., Use of physicochemical parameters in distance geometry and related three-dimensional quantitative structure-activity relationships: A demonstration using Escheria coli dihydrofolate reductase inhibitors, J. Med. Chem., 28 (1985) 333–346.
Cramer, R.D., Patterson, D.E. and Bunce, J.D., Comparative molecular field analysis (CoMFA): I. Effect of shape on binding of steroids to carrier proteins, J. Am. Chem. Soc., 110 (1988) 5959–5967.
Holzgrabe, U. and Hopfinger, A.J., Conformational-analysis, molecular shape comparison, and phar-macophore identification of different allosteric modulators of muscarinic receptors, J. Chem. Inf. Comp. Sci., 36 (1996) 1018–1024.
Hariprasad, V. and Kulkarni, V.M., A proposed common spatial pharmacophore and the corresponding active conformations of some peptide leukotriene receptor antagonists, J. Comput.-Aided Mol. Design, 10 (1996) 284–292.
Barlett, P.A., Shea, J.T. Telfer, S.J. and Waterman, S. CAVEAT: S program to facilitate the structure-derived design of biologically active molecules (Special publ. Molecular recognition in chemical and biological problems), 78 (1989) 182–196.
Tschinke, V. and Cohen, N.C., The NEWLEAD program: A net method for the design of candidate structures from pharmacophore hypothesis. J. Med. Chem., 36 (1993) 3863–3870.
Pickett, S.D., Mason, J.S. and Mclay, I.M., Diversity profiling and design using 3D pharmacophores - pharmacophore-derived queries (pdq), J. Chem. Inf. Comput. Sci. 36 (1996) 1214–1223.
Mattos, C. and Ringe, D., Multiple Binding Modes, In H. Kubinyi (Ed.) 3D QSAR in drug design: Theory, methods and applications, ESCOM, Leiden, 1993, pp. 226–254.
Diana, G.D., Jaeger, E.P., Peterson, M.L. and Treasurywala, A.M., The use of an algorithmic method of small molecule superpositions in the design of antiviral agents, J. Comput.-Aided Mol. Design, 7 (1993), 325–335.
Martin, Y.C., Pharmacophore mapping, In Martin, Y.C. and Willet, P. (Eds) Design of bioactive molecules using 3D structure information, ACS Washington D.C., 1997.
Rights and permissions
About this article
Cite this article
Ghose, A.K., Wendoloski, J.J. Pharmacophore modelling: methods, experimental verification and applications. Perspectives in Drug Discovery and Design 9, 253–271 (1998). https://doi.org/10.1023/A:1027213408430
Issue Date:
DOI: https://doi.org/10.1023/A:1027213408430